These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20941398)

  • 21. Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy.
    Geretti AM; Harrison L; Green H; Sabin C; Hill T; Fearnhill E; Pillay D; Dunn D;
    Clin Infect Dis; 2009 May; 48(9):1296-305. PubMed ID: 19331585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular footprint of drug-selective pressure in a human immunodeficiency virus transmission chain.
    Lemey P; Derdelinckx I; Rambaut A; Van Laethem K; Dumont S; Vermeulen S; Van Wijngaerden E; Vandamme AM
    J Virol; 2005 Sep; 79(18):11981-9. PubMed ID: 16140774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France.
    Chaix ML; Descamps D; Wirden M; Bocket L; Delaugerre C; Tamalet C; Schneider V; Izopet J; Masquelier B; Rouzioux C; Meyer L; Costagliola D; ; ;
    AIDS; 2009 Mar; 23(6):717-24. PubMed ID: 19279445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral diversity and drug resistance mutations before and after one month of antiretroviral therapy in naive patients.
    Epaulard O; Signori-Schmuck A; Larrat S; Kulkarni O; Blum MG; Fusillier K; Blanc M; Leclercq P; François O; Morand P
    J Clin Virol; 2017 Oct; 95():13-19. PubMed ID: 28830014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon.
    Fokam J; Takou D; Teto G; Nforbih SE; Kome OP; Santoro MM; Ngoufack ES; Eyongetah M; Palmer D; Fokunang ET; Fokunang CN; Colizzi V; Perno CF; Ndjolo A
    PLoS One; 2020; 15(7):e0235958. PubMed ID: 32692778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 subtype C dissemination in southern Brazil.
    Soares EA; Martínez AM; Souza TM; Santos AF; Da Hora V; Silveira J; Bastos FI; Tanuri A; Soares MA
    AIDS; 2005 Oct; 19 Suppl 4():S81-6. PubMed ID: 16249660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Within-host and between-host evolutionary rates across the HIV-1 genome.
    Alizon S; Fraser C
    Retrovirology; 2013 May; 10():49. PubMed ID: 23639104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological, Clinical and Antiretroviral Susceptibility Characterization of Human Immunodeficiency Virus Subtypes B and Non-B in Pernambuco, Northeast Brazil.
    Lima K; de Souza Leal É; Cavalcanti AM; Salustiano DM; de Medeiros LB; da Silva SP; Lacerda HR
    PLoS One; 2016; 11(5):e0155854. PubMed ID: 27218259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained virological failure in Cameroonese patient infected by HIV-1 group N evidenced by sequence-based genotyping assay.
    Péré H; Roques P; Talla F; Meillo H; Charpentier C; Bélec L
    AIDS; 2015 Jun; 29(10):1267-9. PubMed ID: 26035326
    [No Abstract]   [Full Text] [Related]  

  • 30. Phylogenetic transmission clusters among newly diagnosed antiretroviral drug-naïve patients with human immunodeficiency virus-1 in Korea: A study from 1999 to 2012.
    Chung YS; Choi JY; Yoo MS; Seong JH; Choi BS; Kang C
    PLoS One; 2019; 14(6):e0217817. PubMed ID: 31166970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.
    Yue L; Pfafferott KJ; Baalwa J; Conrod K; Dong CC; Chui C; Rong R; Claiborne DT; Prince JL; Tang J; Ribeiro RM; Cormier E; Hahn BH; Perelson AS; Shaw GM; Karita E; Gilmour J; Goepfert P; Derdeyn CA; Allen SA; Borrow P; Hunter E
    PLoS Pathog; 2015 Jan; 11(1):e1004565. PubMed ID: 25569444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phylogenetic analysis of HIV-1 subtypes and drug resistance profile among treatment-naïve people in Kuwait.
    Chehadeh W; Albaksami O; Altawalah H; Ahmad S; Madi N; John SE; Abraham PS; Al-Nakib W
    J Med Virol; 2015 Sep; 87(9):1521-6. PubMed ID: 25976289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An HIV epidemic model based on viral load dynamics: value in assessing empirical trends in HIV virulence and community viral load.
    Herbeck JT; Mittler JE; Gottlieb GS; Mullins JI
    PLoS Comput Biol; 2014 Jun; 10(6):e1003673. PubMed ID: 24945322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study.
    Coetzee J; Hunt G; Jaffer M; Otwombe K; Scott L; Bongwe A; Ledwaba J; Molema S; Jewkes R; Gray GE
    PLoS One; 2017; 12(12):e0188606. PubMed ID: 29244809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006.
    Wheeler WH; Ziebell RA; Zabina H; Pieniazek D; Prejean J; Bodnar UR; Mahle KC; Heneine W; Johnson JA; Hall HI;
    AIDS; 2010 May; 24(8):1203-12. PubMed ID: 20395786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epidemiological characteristics of molecular transmission cluster among reported HIV/AIDS cases in Jiaxing city, Zhejiang province, 2017].
    Luo MY; Pan XH; Fan Q; Zhang JF; Ge R; Jiang J; Chen WJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Feb; 40(2):202-206. PubMed ID: 30744273
    [No Abstract]   [Full Text] [Related]  

  • 37. Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains.
    Goudsmit J; Weverling GJ; van der Hoek L; de Ronde A; Miedema F; Coutinho RA; Lange JM; Boerlijst MC
    AIDS; 2001 Nov; 15(17):2293-301. PubMed ID: 11698703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 subtypes: epidemiology and significance for HIV management.
    Geretti AM
    Curr Opin Infect Dis; 2006 Feb; 19(1):1-7. PubMed ID: 16374210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic.
    Grant-McAuley W; Fogel JM; Galai N; Clarke W; Breaud A; Marzinke MA; Mbwambo J; Likindikoki S; Aboud S; Donastorg Y; Perez M; Barrington C; Davis W; Kerrigan D; Eshleman SH
    PLoS One; 2020; 15(10):e0240890. PubMed ID: 33119663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of drug resistance mutations among drug-naive patients in Morocco.
    Annaz HE; Recordon-Pinson P; Baba N; Sedrati O; Mrani S; Fleury H
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):917-20. PubMed ID: 21087198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.